Previous 10 | Next 10 |
home / stock / viv:cc / viv:cc news
*Family-owned dairy business with established reputation for high-quality products turning to OxC-beta™ to support quality of milk * Order procured through Meyenberg International, Avivagen’s Mexican distribution partner Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) ...
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...
6,000 pouches ordered via new and existing customers in Taiwan and Mexico Chris Boland departs role as Chief Financial Officer Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing ...
Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby ...
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting gener...
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”) announces that the TSX Venture Exchange has granted a second extension of up to ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Avivagen Inc. (TSXV:VIV) (“ Avivagen ” or the “ Company ”), a life sciences corporation focused on developing and commercializing products ...
News, Short Squeeze, Breakout and More Instantly...
Avivagen Inc. Company Name:
VIV:CC Stock Symbol:
TSXVC Market:
Yangaroo Inc. (YOO:CA) is expected to report for Q1 2024 Blue Horizon Global Capital Corp Com (BHCC:CNX) is expected to report for Q1 2024 GoldMoney Inc. (XAU:CA) is expected to report for Q4 2024 Avivagen Inc. (VIV:CA) is expected to report for Q2 2024 Imperial Ginseng Products L...
Mission Ready Solutions Inc. (MRS.H:CA) is expected to report for Q1 2024 Imperial Ginseng Products Ltd. (IGP:CA) is expected to report for Q3 2024 PreveCeutical Medical Inc. (PREV:CNX) is expected to report for Q1 2024 Select Sands Corp. (SNS:CA) is expected to report for Q1 2024 ...
Green Impact Partners Inc. (GIP:CA) is expected to report for Q1 2024 AXMIN Inc. (AXM:CA) is expected to report for Q1 2024 Select Sands Corp. (SNS:CA) is expected to report for Q1 2024 PUDO Inc (PDO:CNX) is expected to report for Q4 2024 Pedro Resources Ltd (VBN:CNX) is expected ...